ArticleBMC surgery2026
Comparison of perioperative outcomes between robotic and laparoscopic pancreaticoduodenectomy: a single-center propensity score matching analysis.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundMinimally invasive pancreaticoduodenectomy (MIPD), including laparoscopic PD (LPD) and robotic-assisted PD (RPD), has gradually become prevalent. Comparisons between LPD and RPD remain relatively limited, and conclusions are still controversial. This study aimed to compare the perioperative outcomes between LPD and RPD.
methodsThis was a retrospective study. We reviewed the records of patients who underwent LPD or RPD from January 2019 to December 2024. Perioperative outcomes were compared before and after propensity score matching (PSM).
resultsA total of 375 patients were included in this study, with 180 patients undergoing LPD and 195 undergoing RPD. After PSM, 139 patients were included in each group, and baseline characteristics were well balanced. Compared to the LPD group, the RPD group had a shorter operation time (median 290.00 vs. 355.00 min, P < 0.001), less blood loss (median 100.00 vs. 300.00 mL, P < 0.001), a lower rate of intraoperative red blood cell (RBC) transfusion (21.58% vs. 39.57%, P = 0.001), a lower rate of conversion to open surgery (2.16% vs. 7.91%, P = 0.028), and a shorter postoperative hospital stay (median 13.00 vs. 17.00 days, P = 0.003). There were no significant differences between the two groups in terms of postoperative complications or short-term oncological outcomes.
conclusionRPD offered several advantages over LPD, including shorter operation time, less blood loss, lower rate of conversion, lower rate of intraoperative RBC transfusion, and shorter postoperative hospital stay. For patients with malignant tumors, both LPD and RPD demonstrated similar short-term oncological outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.